Lilly in the News

- 2020 -


Mar 12 AbCellera and Lilly to co-develop antibody therapies for the treatment of COVID-19 ( 

- 2019 -


Mar 04 Lilly Canada and JDRF Canada award post-doctoral fellowships in type 1 diabetes research (

Jan 17 Zymeworks reports second investigational new drug (IND)-submission milestone achieved in Lilly collaboration

- 2018 -

Nov 03 One is too many (The Globe and Mail)
Nov 01 One is too many (Reader's Digest)
Jun 02 Canadian advances in healthcare are fuelled by global investment (Financial Post)
May 25

Perspectives on diversity in Canada’s pharmaceutical industry (Financial Post)

May 14 Lilly to acquire AurKa Pharma
May 10 Double jeopardy: The human impact of psoriatic arthritis (The Globe and Mail)
Jan 22

Innovative Targeting Solutions announces research agreement with Lilly ( 

- 2017 -

Oct 19 Hackers compete to transform the lives of people with arthritis (Newswire)
Jan 18 Lilly and CoLucid Pharmaceuticals announce agreement for Lilly to Acquire CoLucid
Jan 16 Arthritis-inclusive workplaces are good for business (The Globe and Mail)
Jan 15 Zymeworks announces the successful achievement of a research milestone with Lilly in bispecific antibody collaboration (

- 2016 -

Oct 01 Psoriasis in the workplace: Why it matters to employers (Benefits Canada)
Jul 19 Canadians deserve a national dementia strategy (The Globe and Mail)
Jun 01 Psoriasis in the workplace: Why it matters to employers (Benefits Canada)
Jan 08 Zymeworks announces $61.5 million financing to support the clinical development of its pipeline of Azymetric™ antibody therapeutics (

- 2015 -

Apr 13 TVM Life Science Ventures VII announces investment in Esperas Pharma Inc. (
Jan 13 CoLucid Pharmaceuticals, Inc., raises $37.1 million in Series C preferred stock offering (